Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates

Objectives To systematically review the literature pertaining to the prevalence of depression and anxiety in patients with prostate cancer as a function of treatment stage. Design Systematic review and meta-analysis. Participants 4494 patients with prostate cancer from primary research investigations. Primary outcome measure The prevalence of clinical depression and anxiety in patients with prostate cancer as a function of treatment stage. Results We identified 27 full journal articles that met the inclusion criteria for entry into the meta-analysis resulting in a pooled sample size of 4494 patients. The meta-analysis of prevalence rates identified pretreatment, on-treatment and post-treatment depression prevalences of 17.27% (95% CI 15.06% to 19.72%), 14.70% (95% CI 11.92% to 17.99%) and 18.44% (95% CI 15.18% to 22.22%), respectively. Pretreatment, on-treatment and post-treatment anxiety prevalences were 27.04% (95% CI 24.26% to 30.01%), 15.09% (95% CI 12.15% to 18.60%) and 18.49% (95% CI 13.81% to 24.31%), respectively. Conclusions Our findings suggest that the prevalence of depression and anxiety in men with prostate cancer, across the treatment spectrum, is relatively high. In light of the growing emphasis placed on cancer survivorship, we consider that further research within this area is warranted to ensure that psychological distress in patients with prostate cancer is not underdiagnosed and undertreated.

[1]  F. Penedo,et al.  Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis , 2013, Cancer.

[2]  A. Mitchell,et al.  Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[3]  E. Castle,et al.  Evaluation of the association of prostate cancer‐specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer , 2013, Psycho-oncology.

[4]  J. Giesinger,et al.  Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy , 2012, BMC Cancer.

[5]  L. Stafford,et al.  Long-term quality of life in Australian women previously diagnosed with gynaecologic cancer , 2011, Supportive Care in Cancer.

[6]  K. Collins,et al.  Gynecological Cancer Survivors: Assessment of Psychological Distress and Unmet Supportive Care Needs , 2011, Journal of psychosocial oncology.

[7]  A. deFazio,et al.  Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregivers , 2010, The Medical journal of Australia.

[8]  N. Tarrier,et al.  A Longitudinal Investigation of Psychological Disorders in Patients Prior and Subsequent to a Diagnosis of Ovarian Cancer , 2010, Journal of Clinical Psychology in Medical Settings.

[9]  E. Steyerberg,et al.  Do anxiety and distress increase during active surveillance for low risk prostate cancer? , 2010, The Journal of urology.

[10]  C. Sharpley,et al.  Positive (but not negative) punishment predicts anxiety and depression among prostate cancer patients: An exploration of the behaviour analytic model of depression , 2009 .

[11]  A. deFazio,et al.  Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. , 2009, European journal of cancer.

[12]  R. Bekkers,et al.  Depression, anxiety and body image after treatment for invasive stage one epithelial ovarian cancer , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[13]  R. Sabatowski,et al.  Preoperative pain as a risk factor for chronic post‐surgical pain – Six month follow‐up after radical prostatectomy , 2009, European journal of pain.

[14]  E. Steyerberg,et al.  Anxiety and distress during active surveillance for early prostate cancer , 2009, Cancer.

[15]  M. Hoyt,et al.  Insomnia, depression, and distress among outpatients with prostate cancer. , 2009, Applied nursing research : ANR.

[16]  S. Mohile,et al.  Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Steyerberg,et al.  ANXIETY AND DISTRESS DURING ACTIVE SURVEILLANCE FOR EARLY PROSTATE CANCER: A LONGITUDINAL ANALYSIS , 2009 .

[18]  C. Sharpley,et al.  Understanding the causes of depression among prostate cancer patients: development of the effects of prostate cancer on lifestyle questionnaire , 2009, Psycho-oncology.

[19]  F. Penedo,et al.  Depression, social support, and beta-adrenergic transcription control in human ovarian cancer , 2009, Brain, Behavior, and Immunity.

[20]  S. Fosså,et al.  Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors , 2009, BMC Cancer.

[21]  N. Tarrier,et al.  A longitudinal investigation of psychological morbidity in patients with ovarian cancer , 2008, British Journal of Cancer.

[22]  F. Penedo,et al.  Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma , 2008, Clinical Cancer Research.

[23]  Y. Gidron,et al.  Psychological distress and its correlates in ovarian cancer: a systematic review , 2008, Psycho-oncology.

[24]  F. Penedo,et al.  Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Y. Hirayasu,et al.  Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer , 2008, The journal of obstetrics and gynaecology research.

[26]  P. Schwartz,et al.  Quality of life among women after surgery for ovarian cancer , 2008, Palliative and Supportive Care.

[27]  P. Ritvo,et al.  A Qualitative Study Examining Psychosocial Distress, Coping, and Social Support Across the Stages and Phases of Epithelial Ovarian Cancer , 2008, Health care for women international.

[28]  J. Greer,et al.  Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy , 2008, Psycho-oncology.

[29]  D. Dearnaley,et al.  Does active surveillance for men with localized prostate cancer carry psychological morbidity? , 2007, BJU international.

[30]  C. Sharpley,et al.  An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer , 2007, Psycho-oncology.

[31]  S. Fosså,et al.  Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  B Møller,et al.  The future burden of cancer in England: incidence and numbers of new patients in 2020 , 2007, British Journal of Cancer.

[33]  C. Sharpley,et al.  Actual change in anxiety and depression among Australian men with prostate cancer , 2007 .

[34]  M. Biondi,et al.  Depression in cancer patients: a critical review , 2007, Clinical practice and epidemiology in mental health : CP & EMH.

[35]  Phyllis Butow,et al.  Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. , 2007, Gynecologic oncology.

[36]  R. Dunn,et al.  Measuring patients' expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy. , 2006, Urology.

[37]  B. Sjöström,et al.  Pain, psychological distress and health-related quality of life at baseline and 3 months after radical prostatectomy , 2006, BMC nursing.

[38]  H. Huizenga,et al.  Do patients with localized prostate cancer treatment really want more aggressive treatment? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Suzy Lockwood-Rayermann Survivorship issues in ovarian cancer: a review. , 2006, Oncology nursing forum.

[40]  H. D. de Koning,et al.  Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up , 2006, British Journal of Cancer.

[41]  A. Kudelka,et al.  The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer. , 2006, Gynecologic oncology.

[42]  É. Vigneault,et al.  Psychological functioning associated with prostate cancer: cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. , 2005, Journal of pain and symptom management.

[43]  A. Seftel Sexual, psychological and dyadic qualities of the prostate cancer 'couple'. , 2005, The Journal of urology.

[44]  A. Sood,et al.  Psychosocial factors and interleukin‐6 among women with advanced ovarian cancer , 2005, Cancer.

[45]  J. Thornby,et al.  Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy. , 2005, Journal of rehabilitation research and development.

[46]  L. Lacombe,et al.  Insomnia in men treated with radical prostatectomy for prostate cancer , 2005, Psycho-oncology.

[47]  N. Tarrier,et al.  Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. , 2004, British journal of health psychology.

[48]  John Carlson,et al.  Prevalence and predictors of psychological distress among women with ovarian cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  S. Tang,et al.  The Silent Killer: Psychological Issues in Ovarian Cancer , 2003, Holistic nursing practice.

[50]  CM Dickens,et al.  Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer , 2003, Palliative medicine.

[51]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[52]  P. Walsh Quality of life after radical prostatectomy or watchful waiting. , 2003, The Journal of urology.

[53]  G. Kemmler,et al.  Fatigue in ovarian carcinoma patients , 2003, Cancer.

[54]  H. Meltzer,et al.  Psychiatric morbidity among adults living in private households, 2000 , 2003, International review of psychiatry.

[55]  W. Pirl,et al.  Depression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot Study , 2002, Psycho-oncology.

[56]  M. Mason,et al.  The prevalence and predictors of psychological distress in patients with early localized prostate cancer , 2002, BJU international.

[57]  David Cella,et al.  Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study , 2002, Psycho-oncology.

[58]  S. Garber,et al.  Pre- and Post-Radiotherapy Sexual Functioning in Prostate Cancer Patients , 2001 .

[59]  K. Nordin,et al.  Predicting anxiety and depression among cancer patients: a clinical model. , 2001, European journal of cancer.

[60]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[61]  P. Stone,et al.  Fatigue in patients with prostate cancer receiving hormone therapy. , 2000, European journal of cancer.

[62]  D. Gunnell,et al.  Comparison of trends in prostate-cancer mortality in England and Wales and the USA , 2000, The Lancet.

[63]  M. Watson,et al.  Influence of psychological response on survival in breast cancer: a population-based cohort study , 1999, The Lancet.

[64]  C. Nemeroff,et al.  Depression in Patients With Cancer: Diagnosis, Biology, and Treatment , 1995 .

[65]  W W Zung,et al.  A rating instrument for anxiety disorders. , 1971, Psychosomatics.

[66]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[67]  J. Alizargar,et al.  Prevalence of Depression in Patients with Cancer , 2013 .

[68]  J. Petera,et al.  Screening for depression in survivors of metastatic ovarian cancer in a programme of palliative cancer care. , 2009, Bratislava Medical Journal.

[69]  Jane Kidd,et al.  Nurses' perceptions and experiences of communication in the operating theatre: a focus group interview , 2006, BMC nursing.

[70]  Michele L. Ybarra,et al.  Center for Epidemiologic Studies Depression Scale: Review and Revision (CESD and CESD-R). , 2004 .

[71]  Steven Piantadosi,et al.  The prevalence of psychological distress by cancer site , 2001, Psycho-oncology.

[72]  J. Thornby,et al.  Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. , 1999, Radiation oncology investigations.

[73]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[74]  W. Zung A SELF-RATING DEPRESSION SCALE. , 1965, Archives of general psychiatry.